Living with diabetes comes with various challenges, and one of the most concerning complications is peripheral neuropathy, which can lead to a loss of sensation in the feet. This condition puts diabetic patients at risk of developing diabetic foot ulcers (DFU), a dangerous condition associated with an increased risk of mortality. However, a ground-breaking solution has emerged from an Israeli startup: Actics Medical. Their innovative “smart” custom insole, known as the Hybrid+, has the potential to revolutionize diabetic foot care by monitoring a patient’s feet in real time, detecting early signs of ulcers, and even preventing their development.
The Hybrid+ Insole: A Technological Marvel
The Hybrid+ insole is equipped with built-in sensors that measure pressure, temperature, and motion of the foot in real-time. This data is transmitted to a smartphone app, enabling both patients and doctors to monitor foot health closely. Unlike traditional custom orthotics, which are passive and fixed, the Hybrid+ insole offers a dynamic solution that can be adjusted in 52 different ways. This customization empowers patients to redistribute pressure on their feet, reducing the risk of ulceration.
Early Detection and Intervention
The ability to detect diabetic foot ulcers in their early stages is crucial for preventing severe complications. Actics Medical’s insole takes a proactive approach to foot health by alerting healthcare providers of potential ulcerations weeks before they manifest physically. By analyzing the way a person walks and identifying excessive pressure on specific areas of the foot, the app can instruct patients to adjust the insole using a specially developed screwdriver. This adaptability sets the Hybrid+ apart from other products in the market, making it a game-changer for diabetic foot care.
Clinical Trials and Validations
The development of the Hybrid+ insole was not haphazard; rigorous clinical trials were conducted to validate its effectiveness. The sensors embedded in the insole were verified at the walking and movement laboratory at Hadassah University Medical Center in Jerusalem. The trials involved nine patients with different foot pathologies, and the results were highly promising. The insoles proved efficient in identifying and monitoring disorders, allowing precise correction of pressure in affected areas for effective clinical treatment.
A Glimpse of the Future
With diabetes prevalence soaring worldwide, the demand for effective diabetic foot care solutions is on the rise. Currently, the total medical cost of managing diabetic foot disorders in the United States exceeds $13 billion annually, and this number is expected to increase with the growing number of diabetes cases. Actics Medical’s Hybrid+ insole has the potential to significantly reduce these costs by preventing ulcers and associated complications.
The Road Ahead: Beyond Diabetic Foot Care
While the Hybrid+ insole is primarily dedicated to diabetic foot care, its potential applications extend far beyond this scope. Actics Medical’s founder and CEO, Ron Machanian, envisions its use in orthopedics, neuromuscular conditions, sports, and even everyday comfort. As smart technology becomes more prevalent, the Hybrid+ represents a glimpse of the future, where footwear will incorporate cutting-edge technology for enhanced well-being.
Actics Medical’s Hybrid+ insole marks a significant advancement in diabetic foot care, offering a personalized and dynamic solution to prevent diabetic foot ulcers. With its real-time monitoring capabilities and adjustable design, this innovative smart insole has the potential to transform the lives of millions of diabetic patients worldwide. As the world embraces the power of smart technology, the Hybrid+ insole stands at the forefront of a new era in foot health and wellbeing.